Get the Stockscreener App
1.2904
0.31%
-0.0196
Therapeuticsmd Inc stock is traded at $1.2904, with a volume of 31,315.
It is down -0.31% in the last 24 hours and up +22.06% over the past month.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
See More
Previous Close:
$1.31
Open:
$1.33
24h Volume:
31,315
Relative Volume:
0.19
Market Cap:
$15.04M
Revenue:
$996.00K
Net Income/Loss:
$-6.09M
P/E Ratio:
-2.4347
EPS:
-0.53
Net Cash Flow:
$-9.76M
1W Performance:
+11.62%
1M Performance:
+22.06%
6M Performance:
+7.05%
1Y Performance:
-16.55%
1-Day Range:
$1.28
$1.3399
1-Week Range:
$1.15
$1.37
52-Week Range:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Name
Therapeuticsmd Inc
Sector
Phone
561-961-1900
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.2994 | 15.16M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
146.84 | 65.38B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.15 | 44.75B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.135 | 40.97B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.96 | 22.50B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
411.18 | 19.04B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-20 | Downgrade | Jefferies | Hold → Underperform |
| May-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-02-19 | Initiated | Guggenheim | Buy |
| Oct-17-19 | Initiated | H.C. Wainwright | Buy |
| Apr-30-19 | Resumed | Noble Capital Markets | Outperform |
| Jun-15-18 | Initiated | JP Morgan | Overweight |
| Sep-08-17 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-11-17 | Upgrade | Oppenheimer | Perform → Outperform |
| May-09-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-22-16 | Resumed | Jefferies | Buy |
| Nov-22-16 | Initiated | Oppenheimer | Outperform |
| Nov-07-16 | Resumed | Guggenheim | Buy |
| Apr-04-16 | Initiated | Goldman | Buy |
| Dec-08-15 | Reiterated | Jefferies | Buy |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Sep-21-15 | Reiterated | Jefferies | Buy |
| Jun-09-15 | Initiated | Guggenheim | Buy |
| Jul-08-14 | Initiated | FBR Capital | Outperform |
| Apr-17-14 | Reiterated | Noble Financial | Buy |
| Jan-28-14 | Reiterated | Noble Financial | Buy |
View All
Therapeuticsmd Inc Stock (TXMD) Latest News
How TherapeuticsMD Inc. (29TA) stock correlates with oil marketsSwing Trade & Accurate Intraday Trading Signals - newser.com
Why TherapeuticsMD Inc. stock remains a top recommendationQuarterly Earnings Report & Technical Entry and Exit Alerts - newser.com
Can TherapeuticsMD Inc. stock surprise with earnings upside2025 Growth vs Value & AI Enhanced Trading Signals - newser.com
What MACD and RSI say about TherapeuticsMD Inc.2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com
Can a trend reversal in TherapeuticsMD Inc. lead to recoveryInflation Watch & Real-Time Buy Signal Alerts - newser.com
Why TherapeuticsMD Inc. stock is seen as undervalued2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com
Key metrics from TherapeuticsMD Inc.’s quarterly dataJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com
Will TherapeuticsMD Inc. stock benefit from upcoming earnings reportsMarket Trend Summary & Risk Managed Investment Signals - newser.com
How to build a dashboard for TherapeuticsMD Inc. stockWeekly Earnings Recap & Weekly Top Gainers Trade List - newser.com
Why ETFs are accumulating TherapeuticsMD Inc. (29TA) stockDay Trade & AI Enhanced Execution Alerts - newser.com
How to read the order book for TherapeuticsMD Inc.Earnings Miss & Real-Time Volume Triggers - newser.com
Why Jiayin Group Inc. Depositary Receipt stock attracts strong analyst attention - newser.com
Therapeuticsmd Inc Stock (TXMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Therapeuticsmd Inc Stock (TXMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
0.61%
1.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):